Records 1 - 30 (of 106 Records)
|Query Trace: Neoplasms and CTLA4[original query]|
| Signature based on RNA-binding protein-related genes for predicting prognosis and guiding therapy in non-small cell lung cancer.
Frontiers in genetics 2022 9 13 930826.
Miao Ti-Wei, Chen Fang-Ying, Du Long-Yi, Xiao Wei, Fu Juan-Ju
| Alteration in the Immune Microenvironment Based on APC Status in MSS/pMMR Colon Cancer.
Disease markers 2022 2022 3592990.
Lin Haishan, Cao Bangw
| Identification of the prognostic signature based on genomic instability-related alternative splicing in colorectal cancer and its regulatory network.
Frontiers in bioengineering and biotechnology 2022 8 10 841034.
Ding Qiuying, Hou Zhengping, Zhao Zhibo, Chen Yao, Zhao Lei, Xiang Y
| A novel defined m7G regulator signature to investigate the association between molecular characterization and clinical significance in lung adenocarcinoma.
Frontiers in oncology 2022 12 897323.
Dong Yi, Li Yingge, Yao Yi, Song Qib
| An immune-related gene prognostic risk index for pancreatic adenocarcinoma.
Frontiers in immunology 2022 8 13 945878.
Su Yang, Qi Ruoshan, Li Lanying, Wang Xu, Li Sijin, Zhao Xuan, Hou Rui, Ma Wen, Liu Dan, Zheng Junnian, Shi Mi
| The predictive value of pyroptosis for the prognosis and immune escape of bladder cancer.
American journal of translational research 2022 12 14 (11): 7744-7757.
Liu Yang, Pang Zhong-Qi, Han Yan-Song, Shen Lin-Kun, Yao Wen-Hao, Zhang Lu, He Jia-Xin, Shan Yu-Juan, Ren Ming-H
| Association between the side effect induced by COVID-19 vaccines and the immune regulatory gene polymorphism.
Frontiers in immunology 2022 11 13 941497.
Chen Ding-Ping, Wen Ying-Hao, Lin Wei-Tzu, Hsu Fang-Pi
| The Oncogenic and Immunological Roles of Apoptosis Antagonistic Transcription Factors in Human Tumors: A Pan-Cancer Analysis.
Oxidative medicine and cellular longevity 2022 10 2022 3355365.
Lu Feng, Wu Juan, Zou Hongpeng, Yang Xin, Wu Yongbing, Xu Jianj
| Low expression of the metabolism-related gene SLC25A21 predicts unfavourable prognosis in patients with acute myeloid leukaemia.
Frontiers in genetics 2022 10 13 970316.
Wang Wenjun, Liang Qian, Zhao Jingyu, Pan Hong, Gao Zhen, Fang Liwei, Zhou Yuan, Shi J
| Identification and validation of an inflammation-related lncRNAs signature for improving outcomes of patients in colorectal cancer.
Frontiers in genetics 2022 10 13 955240.
Huang Mengjia, Ye Yuqing, Chen Yi, Zhu Junkai, Xu Li, Cheng Wenxuan, Lu Xiaofan, Yan Fangro
| Polymorphisms Related to Iron Homeostasis Associate with Liver Disease in Chronic Hepatitis C.
Viruses 2023 8 15 (8): .
Anna Wróblewska, Anna Woziwodzka, Magda Rybicka, Krzysztof P Bielawski, Katarzyna Sikors
| Functional analysis of CTLA4 promoter variant and its possible implication in colorectal cancer immunotherapy.
Frontiers in medicine 2023 8 10 1160368.
Mariana Angulo-Aguado, Sarah Orjuela-Amarillo, Julián Francisco Mora-Jácome, Lea Paloma Córdoba, Antonio Gallego-Ortiz, Cristian Camilo Gaviria-Sabogal, Nora Contreras, Carlos Figueroa, Oscar Ortega-Recalde, Adrien Morel, Dora Janeth Fonseca-Mendo
| HYDIN mutation status as a potential predictor of immune checkpoint inhibitor efficacy in melanoma.
Aging 2023 8 15 .
Liu Li, Kuang Tianrui, Li Chunlei, Qiu Zhendong, Chen Xiaoyan, Deng Wenho
| Development of a novel copper metabolism-related risk model to predict prognosis and tumor microenvironment of patients with stomach adenocarcinoma.
Frontiers in pharmacology 2023 6 14 1185418.
Dongjie Sun, Haiying Zhang, Chi Zha
| An immune-related biomarker index for predicting the effectiveness of immunotherapy and prognosis in hepatocellular carcinoma.
Journal of cancer research and clinical oncology 2023 6 .
Xiang'an Wu, Bao Jin, Xiao Liu, Yilei Mao, Xueshuai Wan, Shunda
| Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG.
European journal of cancer (Oxford, England : 1990) 2023 5 188 140-151.
Anne Zaremba, Peter Mohr, Ralf Gutzmer, Friedegund Meier, Claudia Pföhler, Michael Weichenthal, Patrick Terheyden, Andrea Forschner, Ulrike Leiter, Jens Ulrich, Jochen Utikal, Julia Welzel, Martin Kaatz, Christoffer Gebhardt, Rudolf Herbst, Anca Sindrilaru, Edgar Dippel, Michael Sachse, Frank Meiss, Lucie Heinzerling, Sebastian Haferkamp, Carsten Weishaupt, Harald Löffler, Sophia Kreft, Klaus Griewank, Elisabeth Livingstone, Dirk Schadendorf, Selma Ugurel, Lisa Zimm
| BRAF V600E/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors.
The oncologist 2023 4 .
Colle Raphael, Lonardi Sara, Cachanado Marine, Overman Michael J, Elez Elena, Fakih Marwan, Corti Francesca, Jayachandran Priya, Svrcek Magali, Dardenne Antoine, Cervantes Baptiste, Duval Alex, Cohen Romain, Pietrantonio Filippo, André Thier
| Integrated analysis of single-cell and bulk RNA sequencing identifies a signature based on macrophage marker genes involved in prostate cancer prognosis and treatment responsiveness.
Functional & integrative genomics 2023 4 23 (2): 115.
Li Xiugai, Zheng Chang, Xue Xiaoxia, Wu Junying, Li Fei, Song Dan, Li Xueli
| Systematic pan-cancer analysis identifies transmembrane protein 158 as a potential therapeutic, prognostic and immunological biomarker.
Functional & integrative genomics 2023 3 23 (2): 105.
Li Jiayi, Hou Haiguang, Sun Jinhao, Ding Zhaoxi, Xu Yingkun, Li Guib
| Gene variations related to the hepatocellular carcinoma: results from a field synopsis and Bayesian revaluation.
Gene 2023 3 147392.
Penha Mesquita Abel, Victor Oliveira Monteiro André, Luiz Araújo Bentes Leal Alessandro, Dos Santos Pessoa Larissa, de Siqueira Amorim Júnior José, Rogério Souza Monteiro José, Andrade de Sousa Aline, Fernando Pereira Vasconcelos Daniel, Carolina Alves de Oliveira Ana, Leão Pereira Adenilson, Rodolfo Pereira da Silva Feli
| TNFSF15 and MIA Variant Associated with Immunotherapy and Prognostic Evaluation in Esophageal Cancer.
Journal of oncology 2023 3 2023 1248024.
You Jun, Bian Jiaojiao, Chen Jian, Xia Tianqin, Deng Ailu, Zhang Ming, Liao YiChen, Wen Huling, Xu Zhengm
| Identification of methyltransferase modification genes associated with prognosis and immune features of pancreatic adenocarcinoma.
Molecular and cellular probes 2023 2 67 101897.
Wang Wentao, Zhang Dongyuan, Chang Donglei, Li Yupeng, Ren L
| Pan-cancer integrated bioinformatics analysis reveals cuproptosis related gene FDX1 is a potential prognostic and immunotherapeutic biomarker for lower-grade gliomas.
Frontiers in molecular biosciences 2023 2 10 963639.
Huang Wei, Wu Yuliang, Zhu Jihui, Luo Ning, Wang Chunyan, Liu Shupeng, Cheng Zhongpi
| Mapping the immunological battlefield in gastric cancer: prognostic implications of an immune gene expression signature.
Discover. Oncology 2023 11 14 (1): 212.
Xianhong Meng, Daxiu Wang, Xueying Sun, Jiangfeng Yuan, Jiwu H
| A circadian clock gene-related signature for predicting prognosis and its association with sorafenib response in hepatocellular carcinoma.
Translational cancer research 2023 11 12 (10): 2493-2507.
Qing Liang, Yongqing Ye, Enze Li, Jingming Fan, Jinglin Gong, Jiaxin Ying, Yawen Cao, Rongqi Li, Ping Wa
| Identification of cancer-associated fibroblasts signature for predicting the prognosis and immunotherapy response in hepatocellular carcinoma.
Medicine 2023 11 102 (45): e35938.
Jianzhong Ye, Wen Tian, Bigeng Zheng, Tao Ze
| Unraveling the prognostic significance and molecular characteristics of tumor-infiltrating B lymphocytes in clear cell renal cell carcinoma through a comprehensive bioinformatics analysis.
Frontiers in immunology 2023 11 14 1238312.
Youwei Yue, Xinyi Cai, Changhao Lu, Leonardo Antonio Sechi, Paolo Solla, Shensuo
| Comprehensive analysis of integrin ?v?3/?6?1 in prognosis and immune escape of prostate cancer.
Aging 2023 10 15 .
Yang Liu, Jia-Xin He, Bo Ji, Jin-Feng Wang, Lu Zhang, Zhong-Qi Pang, Jian-She Wang, Bei-Chen Ding, Ming-Hua R
| Comprehensive bioinformatics analysis of the role of VWF in the tumor microenvironment of malignant mesothelioma.
Medicine 2023 10 102 (41): e35579.
Jiren Weng, Jing Ch
| Molecular subtyping and IMScore based on immune-related pathways, oncogenic pathways, and DNA damage repair pathways for guiding immunotherapy in hepatocellular carcinoma patients.
Journal of gastrointestinal oncology 2023 1 13 (6): 3135-3153.
Yu Zeyan, Vyungura Olivier, Zhao Yinno
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 01, 2023
- Content source: